I think the market where GLP-1s will be the biggest is in the US, he said
Constipation and diarrhea are also common, with some patients experiencing one or both at different phases of treatment, depending on how their bowel habits adapt to slower gastric movement
Stimulation of these receptors by GLP-1RAs may lead to cellular overgrowth, hyperplasia, chronic low-grade, or acute inflammation
Common microdosing approaches The following are the common microdosing approaches: Sustained low dose: Some individuals remain indefinitely on the initial starter dose, such as 0.25 mg of semaglutide weekly, and never exceed this dose
See more from MedicalBrief archives: US study finds serious side effects from weight-loss drugs Patients felled by weight-loss drugs side effects Why I think weight loss drugs are not the answer US obesity expert
But if youre an older adult, your weight loss approach is just as important as how much you lose especially when it comes to maintaining muscle, limiting bone loss, and supporting overall health